Drug and pharmaceutical recalls
17658 federal recalls on file. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass II0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactured by: Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-05.
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIDo not use Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi sodium chloride injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugCipla USA, Inc.Class IIStop using Cipla Lanreotide Injection
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
- 2026-04-15FDA-DrugCipla USA, Inc.Class IIDo not use Cipla Lanreotide Injection
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
- 2026-04-08FDA-PRBlaine Labs, IncStop using Blaine Labs wound care gel
Santa Fe Springs, California – April 07, 2026 – Blaine Labs, Inc. is voluntarily recalling three (3) lot numbers of Wound Care Gel products, 1 oz. & 3 oz. (0.1% Benzalkonium Chloride) to the consumer level due to microbial contamination.
- 2026-04-08FDA-DrugAmneal Pharmaceuticals, LLCClass IStop using Amneal Magnesium Sulfate IV bags
Product mix up: a foil pouch labeled "Magnesium Sulfate in Water for Injection, 4 g/100 mL" actually contained an IV bag of Tranexamic Acid instead.
- 2026-04-08FDA-DrugAppco Pharma LLCClass IIStop using recalled prazosin hydrochloride capsules
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
- 2026-04-08FDA-DrugAppco Pharma LLCClass IIStop using Appco Pharma prazosin capsules
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
- 2026-04-08FDA-DrugAppco Pharma LLCClass IIStop taking recalled prazosin capsules
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
- 2026-04-08FDA-DrugK.C. Pharmaceuticals, IncClass IIStop using recalled artificial tears eye drops
Lack of Assurance of Sterility
- 2026-04-08FDA-DrugK.C. Pharmaceuticals, IncClass IIStop using recalled eye drops immediately
Lack of Assurance of Sterility
- 2026-04-08FDA-DrugK.C. Pharmaceuticals, IncClass IIStop using recalled redness relief eye drops
Lack of Assurance of Sterility
- 2026-04-08FDA-DrugK.C. Pharmaceuticals, IncClass IIStop using recalled sterile eye drops
Lack of Assurance of Sterility
- 2026-04-08FDA-DrugK.C. Pharmaceuticals, IncClass IIStop using recalled lubricating eye drops
Lack of Assurance of Sterility
- 2026-04-08FDA-DrugK.C. Pharmaceuticals, IncClass IIStop using recalled Dry Eye Relief Eye Drops
Lack of Assurance of Sterility
- 2026-04-08FDA-DrugK.C. Pharmaceuticals, IncClass IIStop using Advanced Relief eye drops
Lack of Assurance of Sterility
- 2026-04-08FDA-DrugK.C. Pharmaceuticals, IncClass IIStop using recalled sterile eye drops
Lack of Assurance of Sterility
- 2026-04-08FDA-DrugAmneal Pharmaceuticals, LLCClass IIStop using Amneal tramadol tablets
Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term stability (25¿C/60%RH).
- 2026-04-08FDA-DrugALEMBIC PHARMACEUTICALS, INC.Class IIStop using Alembic Bromfenac eye drops
Failed Impurities/Degradation Specifications: out of specification at the time of testing i.e. 20th month stability testing.
- 2026-04-06FDA-PRNalpacStop using Nalpac DTF Sexual Chocolate
FOR IMMEDIATE RELEASE – Date – Ferndale, Michigan. Nalpac is voluntarily recalling DTF Sexual Chocolate it purchased and resold. The products have been found to contain sildenafil and tadalafil.
- 2026-04-01FDA-DrugAmerisource Health Services LLCClass IIStop using recalled Meclizine Hydrochloride tablets
Failed tablet specifications.
- 2026-04-01FDA-DrugTeva Pharmaceuticals USA, IncClass IIStop using recalled Teva Octreotide Acetate injections
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
Get notified about new drug recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.
Get the Sunday Brief